Insider Transaction: Kris Canekeratne Sold 12,000 Shares of Virtusa (VRTU); Nepsis Capital Management Trimmed Johnson & Johnson (JNJ) Holding By $693,680

Nepsis Capital Management Inc decreased Johnson & Johnson (JNJ) stake by 9.78% reported in 2017Q3 SEC filing. Nepsis Capital Management Inc sold 5,336 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Nepsis Capital Management Inc holds 49,203 shares with $6.40M value, down from 54,539 last quarter. Johnson & Johnson now has $360.45 billion valuation. The stock increased 1.30% or $1.72 during the last trading session, reaching $134.35. About 9.15 million shares traded or 16.45% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since March 14, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Kris Canekeratne, the insider, presently the Chairman & CEO of Virtusa Corp sold just 12,000 shares of the corporation valued by the stock market at $614,584 U.S Dollars estimated based on 51.2 U.S Dollars per every share. This is not his first insider trade, in the last month, he sold another 25,000 shares worth $1,216,237 USD. The sale was made on March 13, 2018 and this act was unveiled in a document which was filed with the Washington-based SEC. This document is free at your disposal for review here. The probability that this sell remains unseen is quite small on account of the large amount of money involved. Currently, Kris Canekeratne owns 810,692 shares which are about 2.75% of the company’s market cap (total dollar market value of all company’s outstanding shares).

Nepsis Capital Management Inc increased Baidu Inc (NASDAQ:BIDU) stake by 3,446 shares to 43,951 valued at $10.89 million in 2017Q3. It also upped United States Stl Corp New (NYSE:X) stake by 80,917 shares and now owns 137,539 shares. China Rapid Fin Ltd was raised too.

Since February 15, 2018, it had 0 buys, and 1 sale for $20.17 million activity. The insider Stoffels Paulus sold 155,342 shares worth $20.17 million.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on April, 17. They expect $2.01 earnings per share, up 9.84% or $0.18 from last year’s $1.83 per share. JNJ’s profit will be $5.39B for 16.71 P/E if the $2.01 EPS becomes a reality. After $1.74 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 15.52% EPS growth.

Investors sentiment increased to 0.87 in 2017 Q3. Its up 0.04, from 0.83 in 2017Q2. It improved, as 45 investors sold JNJ shares while 871 reduced holdings. 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Moreover, Grace White New York has 1.28% invested in Johnson & Johnson (NYSE:JNJ) for 47,466 shares. Suntrust Banks stated it has 1.24M shares. Moreover, Services Inc has 0.09% invested in Johnson & Johnson (NYSE:JNJ). Gfs Advsr invested 2.11% in Johnson & Johnson (NYSE:JNJ). Obermeyer Wood Counsel Lllp holds 0.19% or 16,478 shares in its portfolio. United Fire Gp has invested 1.66% in Johnson & Johnson (NYSE:JNJ). 114,386 are held by Sandy Spring Comml Bank. Walter And Keenan Fincl Consulting Co Mi Adv, a Indiana-based fund reported 54,749 shares. Wms Ltd holds 3.03% or 195,461 shares in its portfolio. Gulf Int Bancorporation (Uk) holds 851,180 shares or 1.49% of its portfolio. Central owns 85,000 shares for 1.89% of their portfolio. Northern Cap Ltd holds 33,441 shares. 213,106 were accumulated by Crestwood Advsr Gp Llc. Jolley Asset Llc, a North Carolina-based fund reported 773 shares. Adams Diversified Equity Fund Inc stated it has 241,900 shares or 1.71% of all its holdings.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 91 analyst reports since August 7, 2015 according to SRatingsIntel. On Tuesday, September 22 the stock rating was initiated by UBS with “Buy”. The company was maintained on Wednesday, August 2 by BTIG Research. Piper Jaffray reinitiated the stock with “Neutral” rating in Monday, October 5 report. Atlantic Securities initiated Johnson & Johnson (NYSE:JNJ) rating on Friday, December 18. Atlantic Securities has “Neutral” rating and $95 target. The stock has “Buy” rating by Credit Suisse on Thursday, October 19. The stock of Johnson & Johnson (NYSE:JNJ) has “Outperform” rating given on Wednesday, October 7 by RBC Capital Markets. Argus Research upgraded Johnson & Johnson (NYSE:JNJ) rating on Wednesday, July 20. Argus Research has “Buy” rating and $145 target. The firm has “Neutral” rating by Goldman Sachs given on Monday, March 14. The firm has “Hold” rating by Piper Jaffray given on Tuesday, July 18. The company was maintained on Sunday, August 27 by RBC Capital Markets.

Among 10 analysts covering Virtusa (NASDAQ:VRTU), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Virtusa has $67 highest and $24 lowest target. $53’s average target is 2.91% above currents $51.5 stock price. Virtusa had 34 analyst reports since July 29, 2015 according to SRatingsIntel. Needham maintained the stock with “Buy” rating in Tuesday, February 9 report. Cowen & Co upgraded the stock to “Outperform” rating in Friday, March 24 report. Cantor Fitzgerald initiated the stock with “Buy” rating in Friday, October 16 report. The rating was upgraded by Wedbush on Friday, January 6 to “Outperform”. The rating was maintained by Needham with “Buy” on Thursday, February 8. The rating was maintained by Maxim Group on Wednesday, January 25 with “Buy”. The stock has “Buy” rating by Maxim Group on Thursday, November 10. The company was initiated on Friday, September 9 by Wedbush. Needham maintained Virtusa Corporation (NASDAQ:VRTU) rating on Thursday, November 5. Needham has “Buy” rating and $65 target. Sterne Agee CRT initiated the stock with “Neutral” rating in Thursday, December 17 report.

Analysts await Virtusa Corporation (NASDAQ:VRTU) to report earnings on May, 15. They expect $0.37 earnings per share, up 48.00% or $0.12 from last year’s $0.25 per share. VRTU’s profit will be $10.89M for 34.80 P/E if the $0.37 EPS becomes a reality. After $0.19 actual earnings per share reported by Virtusa Corporation for the previous quarter, Wall Street now forecasts 94.74% EPS growth.

Since September 18, 2017, it had 0 insider buys, and 13 insider sales for $4.67 million activity. $142,808 worth of stock was sold by Canekeratne Kris A on Thursday, March 1. On Monday, February 12 the insider Rajgopal Raj sold $191,309. DAVOLI ROBERT E also sold $68,186 worth of Virtusa Corporation (NASDAQ:VRTU) on Tuesday, December 12.

Virtusa Corporation operates as an information technology services company. The company has market cap of $1.52 billion. It offers business and IT consulting services comprising advisory/target operating model, business process re-engineering/BPM, transformational solution consulting, and business/technology alignment analysis; omni-channel digital strategy, experience design ASD, and employee engagement; and application portfolio rationalization, SDLC transformation, and BA competency transformation services. It has a 260.1 P/E ratio. The firm also provides technology implementation services, such as application development, software product engineering, CRM and SAP implementation, content management, enterprise mobility, cloud computing, and social media solutions; systems consolidation and rationalization, technology migration and porting, and legacy application Web-enablement; data management, business intelligence, reporting and decision support, master data management, data integration, and big data analytics; and software quality assurance and managed testing services.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: